Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) have earned a consensus recommendation of “Reduce” from the seven brokerages that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has assigned a buy recommendation to […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.